FERHANOĞLU, A. B. Et Al. 2017. Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey. The 22nd European Hematology Congress , (Madrid, Spain), 84.

FERHANOĞLU, A. B., BEKÖZ, H. S., KARADURMUŞ, N., PAYDAŞ, S., GÜLBAŞ, Z., TÜRKER, F. A., ... TOPTAŞ, T.(2017). Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey . The 22nd European Hematology Congress (pp.84). Madrid, Spain

FERHANOĞLU, AHMET Et Al. "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey," The 22nd European Hematology Congress, Madrid, Spain, 2017

FERHANOĞLU, AHMET B. Et Al. "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey." The 22nd European Hematology Congress , Madrid, Spain, pp.84, 2017

FERHANOĞLU, A. B. Et Al. (2017) . "Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey." The 22nd European Hematology Congress , Madrid, Spain, p.84.

@conferencepaper{conferencepaper, author={AHMET BURHAN FERHANOĞLU Et Al. }, title={Nivolumab for Relapsed or Refractory Hodgkin Lymphoma: Experience in Turkey}, congress name={The 22nd European Hematology Congress}, city={Madrid}, country={Spain}, year={2017}, pages={84} }